Mossé YP - Search Results

1

Evaluation of the DLL3-targeting antibody-drug conjugate rovalpituzumab tesirine in preclinical models of neuroblastoma.

Krytska K, Casey CE, Pogoriler J, Martinez D, Rathi KS, Farrel A, Berko ER, Tsang M, Sano RR, Kendsersky N, Erickson SW, Teicher BA, Isse K, Saunders L, Smith MA, Maris JM, Mossé YP. Krytska K, et al. Among authors: mosse yp. Cancer Res Commun. 2022 Jul;2(7):616-623. doi: 10.1158/2767-9764.crc-22-0137. Epub 2022 Jul 11. Cancer Res Commun. 2022. PMID: 36381237 Free PMC article.

2

Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13.

Maris JM, Weiss MJ, Mosse Y, Hii G, Guo C, White PS, Hogarty MD, Mirensky T, Brodeur GM, Rebbeck TR, Urbanek M, Shusterman S. Maris JM, et al. Cancer Res. 2002 Nov 15;62(22):6651-8. Cancer Res. 2002. PMID: 12438263

3

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

Wang Q, Hii G, Shusterman S, Mosse Y, Winter CL, Guo C, Zhao H, Rappaport E, Hogarty MD, Maris JM. Wang Q, et al. Cancer Res. 2003 Apr 1;63(7):1631-5. Cancer Res. 2003. PMID: 12670915

4

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma.

Mosse Y, Greshock J, King A, Khazi D, Weber BL, Maris JM. Mosse Y, et al. Lancet Oncol. 2003 Dec;4(12):769-71. doi: 10.1016/s1470-2045(03)01283-x. Lancet Oncol. 2003. PMID: 14662434 No abstract available.

5

Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.

Morowitz M, Shusterman S, Mosse Y, Hii G, Winter CL, Khazi D, Wang Q, King R, Maris JM. Morowitz M, et al. Mod Pathol. 2003 Dec;16(12):1248-56. doi: 10.1097/01.MP.0000097364.64566.81. Mod Pathol. 2003. PMID: 14681326

6

High-resolution detection and mapping of genomic DNA alterations in neuroblastoma.

Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL, Maris JM. Mosse YP, et al. Genes Chromosomes Cancer. 2005 Aug;43(4):390-403. doi: 10.1002/gcc.20198. Genes Chromosomes Cancer. 2005. PMID: 15892104

7

CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number data.

Margolin AA, Greshock J, Naylor TL, Mosse Y, Maris JM, Bignell G, Saeed AI, Quackenbush J, Weber BL. Margolin AA, et al. Bioinformatics. 2005 Aug 1;21(15):3308-11. doi: 10.1093/bioinformatics/bti500. Epub 2005 May 19. Bioinformatics. 2005. PMID: 15905276

8

Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.

Mosse YP, Greshock J, Weber BL, Maris JM. Mosse YP, et al. Cancer Lett. 2005 Oct 18;228(1-2):83-90. doi: 10.1016/j.canlet.2005.02.052. Cancer Lett. 2005. PMID: 15967571 Review.

9

Chromosome 1p and 11q deletions and outcome in neuroblastoma.

Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM; Children's Oncology Group. Attiyeh EF, et al. Among authors: mosse yp. N Engl J Med. 2005 Nov 24;353(21):2243-53. doi: 10.1056/NEJMoa052399. N Engl J Med. 2005. PMID: 16306521 Free article.

10

Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.

Wang Q, Diskin S, Rappaport E, Attiyeh E, Mosse Y, Shue D, Seiser E, Jagannathan J, Shusterman S, Bansal M, Khazi D, Winter C, Okawa E, Grant G, Cnaan A, Zhao H, Cheung NK, Gerald W, London W, Matthay KK, Brodeur GM, Maris JM. Wang Q, et al. Cancer Res. 2006 Jun 15;66(12):6050-62. doi: 10.1158/0008-5472.CAN-05-4618. Cancer Res. 2006. PMID: 16778177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page